NR3C1 is required for normal somatotrope differentiation and Foxo1 expression in pituitary

Read full text
Authors: Pratyusa Das, Ridwanullah A Abubakar, Nooshin Mojahed, Dania Abou-Jabal, Prisha Kittu, Michelle Lynn Brinkmeier, Jessica Olsen, Dale Ann Sunny, Sally Ann Camper, Robin Lovell-Badge, Karine Rizzoti, Buffy Sue Ellsworth
Cited by: 1
References: 74

Abstract

Glucocorticoids are an important signal for the differentiation of many types of cells. Consistent with this, several studies have demonstrated that glucocorticoids promote the somatotrope differentiation program and functionality. Interestingly, we previously found that loss of the forkhead factor, FOXO1, results in delayed emergence of somatotropes and prevents glucocorticoid-induced premature differentiation of somatotropes. In the present study, we find that pituitary-specific deletion of Nr3c1, the gene encoding the glucocorticoid receptor, impairs somatotrope differentiation and increases lactotrope numbers embryonically and at 5 days after birth. The number of somatotropes remains reduced at age 7 weeks in females and males, but lactotrope cell numbers are increased only in females at this age. FOXO1 is nearly undetectable in pituitary glands from mouse embryos lacking NR3C1 and continues to be reduced in adults. These findings suggest that glucocorticoids are an important signal for determining the balance between somatotropes and lactotropes and that FOXO1 may mediate NR3C1 induction of somatotrope differentiation.

Fields of Study & Subjects

FOXO transcription factor regulation Growth Hormone and Insulin-like Growth Factors Stress Responses and Cortisol

Publication details

Journal / source
Endocrinology
Publisher
The Endocrine Society
Volume
167
Issue
7
Publication date
15 May 2026
Language
EN